Skip to main content
. 2021 Feb 28;20:1533033821990074. doi: 10.1177/1533033821990074

Figure 1.

Figure 1.

Expression patterns and roles of lncRNA GAS5 in patients with laryngeal cancer. (A) lncRNA GAS5 expression in laryngeal cancer tissues and adjacent normal tissues. (B) Significant downregulation of lncRNA GAS5 (77.5%, 31/40) in patients with laryngeal cancer. (C) Relationship between lncRNA GAS5 expression and tumor differentiation. (D) Relationship between lncRNA GAS5 expression and TMN stage. (E) Relationship between lncRNA GAS5 expression and lymph node metastasis. (F) Kaplan–Meier curves of the overall survival of laryngeal cancer patients with high and low lncRNA GAS5 expression. *P < 0.05, **P < 0.01, ***P < 0.001.